Blonder Tongue Laboratories, Inc.
BDRL
$0.062
$0.000.00%
| 12/31/2022 | 09/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | 0.30% | 24.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.30% | 24.28% | |||
| Cost of Revenue | -16.40% | 21.42% | |||
| Gross Profit | 46.02% | 32.83% | |||
| SG&A Expenses | -8.53% | -1.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.68% | 10.41% | |||
| Operating Income | 168.63% | 50.62% | |||
| Income Before Tax | 112.80% | 39.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 112.80% | 39.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 112.80% | 39.08% | |||
| EBIT | 168.63% | 50.62% | |||
| EBITDA | 176.82% | 51.60% | |||
| EPS Basic | 112.71% | 39.22% | |||
| Normalized Basic EPS | 112.73% | 39.11% | |||
| EPS Diluted | 112.71% | 41.44% | |||
| Normalized Diluted EPS | 112.73% | 39.11% | |||
| Average Basic Shares Outstanding | 0.11% | 0.12% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
